open access

Vol 67, No 6 (2016)
Case report
Submitted: 2016-02-02
Accepted: 2016-06-04
Published online: 2016-12-31
Get Citation

Mikulicz’s Disease with hypophysitis — a new IgG4-mediated disorder

Nikhil M. Bhagwat, Parimal S. Tayde, Pradeep P. Dalwadi, Jehangir Sorabjee, Premlata K. Varthakavi
·
Pubmed: 28042654
·
Endokrynol Pol 2016;67(6):622-626.

open access

Vol 67, No 6 (2016)
Case report
Submitted: 2016-02-02
Accepted: 2016-06-04
Published online: 2016-12-31

Abstract

Introduction: We present a case of Mikulicz’s Disease with hypophysitis. This is a rare clinical association as part of the group of IgG4- related diseases, a group of disorders which can have multiorgan involvement.

Methods: A 55-year-old male patient was diagnosed with Mikulicz’s disease. He was treated with oral steroids for six months with complete resolution. After two years the patient presented with fatigue, generalised weakness, and weight loss of 11 kg over six months. On evaluation he was found to have panhypopituitarism. MRI pituitary revealed homogeneously enlarged, well enhancing pituitary with thickening of the stalk. Serum IgG4 levels were significantly elevated. The patient was treated with methyl prednisolone pulse therapy followed by oral steroids for three months. He developed diabetes insipidus after starting steroid therapy. There was a significant resolution in the enlargement of the pituitary and stalk thickening at three months.

Results: The clinical, biochemical, and radiological findings of hypophysitis associated with Mikulicz’s disease are presented with a brief review of literature.

Conclusions: IgG4-related diseases are rare and have recently been recognised as a cause of hypophysitis. They can have multiorgan involvement. A high index of suspicion is required for clinching this rare diagnosis, which can be confirmed by measurement of serum levels of IgG4. Steroid therapy can reverse the inflammatory changes in IgG4 hypophysitis. (Endokrynol Pol 2016; 67 (6): 622–626)

Abstract

Introduction: We present a case of Mikulicz’s Disease with hypophysitis. This is a rare clinical association as part of the group of IgG4- related diseases, a group of disorders which can have multiorgan involvement.

Methods: A 55-year-old male patient was diagnosed with Mikulicz’s disease. He was treated with oral steroids for six months with complete resolution. After two years the patient presented with fatigue, generalised weakness, and weight loss of 11 kg over six months. On evaluation he was found to have panhypopituitarism. MRI pituitary revealed homogeneously enlarged, well enhancing pituitary with thickening of the stalk. Serum IgG4 levels were significantly elevated. The patient was treated with methyl prednisolone pulse therapy followed by oral steroids for three months. He developed diabetes insipidus after starting steroid therapy. There was a significant resolution in the enlargement of the pituitary and stalk thickening at three months.

Results: The clinical, biochemical, and radiological findings of hypophysitis associated with Mikulicz’s disease are presented with a brief review of literature.

Conclusions: IgG4-related diseases are rare and have recently been recognised as a cause of hypophysitis. They can have multiorgan involvement. A high index of suspicion is required for clinching this rare diagnosis, which can be confirmed by measurement of serum levels of IgG4. Steroid therapy can reverse the inflammatory changes in IgG4 hypophysitis. (Endokrynol Pol 2016; 67 (6): 622–626)

Get Citation

Keywords

IgG4; hypophysitis; Mikulicz’s disease

About this article
Title

Mikulicz’s Disease with hypophysitis — a new IgG4-mediated disorder

Journal

Endokrynologia Polska

Issue

Vol 67, No 6 (2016)

Article type

Case report

Pages

622-626

Published online

2016-12-31

Page views

1660

Article views/downloads

2429

DOI

10.5603/EP.2016.0071

Pubmed

28042654

Bibliographic record

Endokrynol Pol 2016;67(6):622-626.

Keywords

IgG4
hypophysitis
Mikulicz’s disease

Authors

Nikhil M. Bhagwat
Parimal S. Tayde
Pradeep P. Dalwadi
Jehangir Sorabjee
Premlata K. Varthakavi

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą jest  VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl